Glycosylated Hemoglobin and its Role as a Marker of Mortality in Severe Pneumonia by Covid-19

Abstract

Lizeth Tatiana Gonzalez Ramirez, Andres Camilo Angarita Guerrero, Ana Maria Merlano Calderon, Sergio Alejandro Silva Vargas, Osnaider Andres Cuello Torres, Estivinson Reverol Padilla, Adriana Marcela Guzman Naranjo, Jesus David Montero Perez, Abraham Jose Ovalle Ortiz

Since the onset of the covid-19 pandemic in 2020, several aspects have been investigated to predict the prognosis of this disease, including glycosylated hemoglobin (HbA1c). Glycosylated hemoglobin has been studied as a prognostic value for different diseases, initially diabetes, cardiovascular problems, gestational diabetes and nowadays covid-19 pneumonia, HbA1c has been useful to prevent and predict possible complications and the risk of death in patients with covid-19. It has been described that patients with glycosylated hemoglobin values higher than 7% tend to have a higher risk, thus noting that HbA1c may be useful as a prognostic factor for severity and mortality in patients with poor glycemic control and Covid-19 pneumonia.

PDF